全文获取类型
收费全文 | 146841篇 |
免费 | 32382篇 |
国内免费 | 2388篇 |
专业分类
耳鼻咽喉 | 5153篇 |
儿科学 | 5322篇 |
妇产科学 | 2348篇 |
基础医学 | 2844篇 |
口腔科学 | 1457篇 |
临床医学 | 26422篇 |
内科学 | 46483篇 |
皮肤病学 | 7274篇 |
神经病学 | 14602篇 |
特种医学 | 6291篇 |
外科学 | 40616篇 |
综合类 | 227篇 |
现状与发展 | 72篇 |
预防医学 | 6867篇 |
眼科学 | 3311篇 |
药学 | 834篇 |
中国医学 | 6篇 |
肿瘤学 | 11482篇 |
出版年
2023年 | 4775篇 |
2022年 | 1146篇 |
2021年 | 3031篇 |
2020年 | 5997篇 |
2019年 | 2114篇 |
2018年 | 7332篇 |
2017年 | 7294篇 |
2016年 | 8367篇 |
2015年 | 8354篇 |
2014年 | 15414篇 |
2013年 | 15521篇 |
2012年 | 5317篇 |
2011年 | 5318篇 |
2010年 | 10261篇 |
2009年 | 14161篇 |
2008年 | 5651篇 |
2007年 | 3875篇 |
2006年 | 6351篇 |
2005年 | 3637篇 |
2004年 | 2910篇 |
2003年 | 1894篇 |
2002年 | 1984篇 |
2001年 | 3752篇 |
2000年 | 2974篇 |
1999年 | 3180篇 |
1998年 | 3615篇 |
1997年 | 3384篇 |
1996年 | 3340篇 |
1995年 | 3191篇 |
1994年 | 1931篇 |
1993年 | 1555篇 |
1992年 | 1346篇 |
1991年 | 1399篇 |
1990年 | 1048篇 |
1989年 | 1169篇 |
1988年 | 1007篇 |
1987年 | 831篇 |
1986年 | 880篇 |
1985年 | 710篇 |
1984年 | 541篇 |
1983年 | 514篇 |
1982年 | 507篇 |
1981年 | 392篇 |
1980年 | 354篇 |
1979年 | 306篇 |
1978年 | 328篇 |
1977年 | 396篇 |
1975年 | 277篇 |
1972年 | 279篇 |
1970年 | 253篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
71.
Marc Evans MD Susanne Engberg MD Mads Faurby MSc João Diogo Da Rocha Fernandes MSc Pollyanna Hudson MSc William Polonsky PhD 《Diabetes, obesity & metabolism》2022,24(3):377-390
We designed a systematic literature review to identify available evidence on adherence to and persistence with antidiabetic medication in people with type 2 diabetes (T2D). Electronic screening and congress searches identified real-world noninterventional studies (published between 2010 and October 2020) reporting estimates of adherence to and persistence with antidiabetic medication in adults with T2D, and associations with glycaemic control, microvascular and/or macrovascular complications, hospitalizations and healthcare costs. Ninety-two relevant studies were identified, the majority of which were retrospective and reported US data. The proportions of patients considered adherent (median [range] 51.2% [9.4%-84.3%]) or persistent (median [range] 47.7% [16.9%-94.0%]) varied widely across studies. Multiple studies reported an association between greater adherence/persistence and greater reductions in glycated haemoglobin levels. Better adherence/persistence was associated with fewer microvascular and/or macrovascular outcomes, although there was little consistency across studies in terms of which outcomes were improved. More adherent and more persistent patients were typically less likely to be hospitalized or to have emergency department visits/admissions and spent fewer days in hospital annually than less adherent/persistent patients. Greater adherence and persistence were generally associated with lower hospitalization costs, higher pharmacy costs and lower or budget-neutral total healthcare costs compared with lower adherence/persistence. In conclusion, better adherence and persistence in people with T2D is associated with lower rates of microvascular and/or macrovascular outcomes and inpatient hospitalization, and lower or budget-neutral total healthcare expenditure. Education and treatment strategies to address suboptimal adherence and persistence are needed to improve clinical and economic outcomes. 相似文献
72.
73.
74.
75.
76.
77.
78.
Cheryl L. Rock PhD RD Cynthia A. Thomson PhD RD Kristen R. Sullivan MS MPH Carol L. Howe MD MLS Lawrence H. Kushi ScD Bette J. Caan DrPH Marian L. Neuhouser PhD RD Elisa V. Bandera MD PhD Ying Wang PhD Kimberly Robien PhD RD Karen M. Basen-Engquist PhD MPH Justin C. Brown PhD Kerry S. Courneya PhD Tracy E. Crane PhD RDN David O. Garcia PhD FACSM Barbara L. Grant MS RDN CSO FAND Kathryn K. Hamilton MA RDN CSO CDN FAND Sheri J. Hartman PhD Stacey A. Kenfield ScD Maria Elena Martinez PhD Jeffrey A. Meyerhardt MD MPH Larissa Nekhlyudov MD MPH Linda Overholser MD Alpa V. Patel PhD Bernardine M. Pinto PhD Mary E. Platek PhD RD CDN Erika Rees-Punia PhD MPH Colleen K. Spees PhD MEd RD LD FAND Susan M. Gapstur PhD Marjorie L. McCullough ScD RD 《CA: a cancer journal for clinicians》2022,72(3):230-262
The overall 5-year relative survival rate for all cancers combined is now 68%, and there are over 16.9 million survivors in the United States. Evidence from laboratory and observational studies suggests that factors such as diet, physical activity, and obesity may affect risk for recurrence and overall survival after a cancer diagnosis. The purpose of this American Cancer Society guideline is to provide evidence-based, cancer-specific recommendations for anthropometric parameters, physical activity, diet, and alcohol intake for reducing recurrence and cancer-specific and overall mortality. The audiences for this guideline are health care providers caring for cancer survivors as well as cancer survivors and their families. The guideline is intended to serve as a resource for informing American Cancer Society programs, health policy, and the media. Sources of evidence that form the basis of this guideline are systematic literature reviews, meta-analyses, pooled analyses of cohort studies, and large randomized clinical trials published since 2012. Recommendations for nutrition and physical activity during cancer treatment, informed by current practice, large cancer care organizations, and reviews of other expert bodies, are also presented. To provide additional context for the guidelines, the authors also include information on the relationship between health-related behaviors and comorbidities, long-term sequelae and patient-reported outcomes, and health disparities, with attention to enabling survivors' ability to adhere to recommendations. Approaches to meet survivors' needs are addressed as well as clinical care coordination and resources for nutrition and physical activity counseling after a cancer diagnosis. 相似文献
79.
80.